Exchange: NASDAQ·Updated 07:30 PM EDT
News
all
press releases
Should You Continue to Hold ACHC Stock at an 18.17X P/E Valuation?
ACHC's premium valuation faces a key test as facility growth and stronger EBITDA guidance compete with rising costs and weaker returns.
Zacks
More News
LifeStance Health Group (LFST) Is Up 3.44% in One Week: What You Should Know
Does LifeStance Health Group (LFST) have what it takes to be a top stock pick for momentum investors? Let's find out.
Zacks
Zacks.com featured highlights include LifeStance Health, Tutor Perini, Valero Energy, SharkNinja and Lumentum
Low-leverage stocks like LifeStance Health, Tutor Perini, Valero Energy, SharkNinja and Lumentum offer resilience amid oil and geopolitical risks.
Zacks
5 Low-Leverage Stocks to Buy as High Oil Prices Shake Investor Confidence
High oil prices and market volatility spotlight five low-leverage stocks with strong earnings growth and resilient balance sheets.
Zacks
LifeStance Health (LFST) Upgraded to Buy: Here's Why
LifeStance Health (LFST) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Zacks
LifeStance Health Group, Inc. (LFST) Soars to 52-Week High, Time to Cash Out?
LifeStance Health (LFST) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Zacks
LifeStance Survey Finds Women Want Mental Healthcare Built Into Perimenopause and Menopause Care
LifeStance Survey Finds Women Want Mental Healthcare Built Into Perimenopause and Menopause Care LifeStance Survey Finds Women Want Mental Healthcare Built Into Perimenopause and Menopause Care PR Newswire SCOTTSDALE, Ariz., Aug. 11, 2026 One in Three Women Don't Know Perimenopause Can Cause...
PR Newswire
LifeStance Health Group (LFST) Tops Q2 Earnings and Revenue Estimates
LifeStance Health (LFST) delivered earnings and revenue surprises of +100.00% and +5.08%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks
Elanco Animal Health Incorporated (ELAN) Q2 Earnings and Revenues Beat Estimates
Elanco Animal Health (ELAN) delivered earnings and revenue surprises of +25.93% and +4.41%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks
DaVita HealthCare (DVA) Q2 Earnings and Revenues Top Estimates
DaVita HealthCare (DVA) delivered earnings and revenue surprises of +0.25% and +0.61%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks

Advertisement|Remove ads.